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Abstract
Background: To assess the effect of rostral anterior cingulate cortex (rACC) administration with ifenprodil (NR2B
receptor blocker) on bone cancer pain (BCP)-related aversion sentiment using the conditioned place avoidance
experiments in rats.
Methods: A total of 30 male Wistar rats without place preference were randomly assigned to three groups: control
group (Group C, n = 10), BCP group (Group P, n = 10) and ifenprodil group (Group Ifen, n = 10). Three microliter
MADB-106 cells were inoculated into right tibia bone marrow cavity in group P and Ifen, while the same dose of
normal saline in group C as a control. Ifenprodil was administered into the rACC at the 14th day after inoculation in
group Ifen and normal saline in group C and P. Mechanical stimulation pain thresholds of the rats’ right hind paws
were measured using Von Frey stimulation method at 1 day before injection of the tumor cells and at 3, 7,10, 12
and 14 days after the injection. The pain-related aversion in rats with BCP was determined by the conditioned place
avoidance (CPA) test at 14 days after injection of ifenprodil.
Results: The mechanical stimulation pain thresholds substantially decreased in rats in groups P and Ifen from
10 days to 14 days after the incubation with the MADB-106 cells (P < 0.05). There were significant differences in
pain thresholds in groups P and Ifen compared to group C at 10, 12 and 14 days after inoculation (P < 0.05). The
percentage of residence time in chamber A was (30 ± 4%) in group P, which was lower than (52 ± 5%) in group C
(P < 0.05). After ifenprodil treatment, the percentage time in chamber A increased to (42 ± 5%), which was higher
than that in group P and still lower than that in group C (P < 0.05).
Conclusion: Ifenprodil administered into rACC as a selective NR2B antagonist can effectively alleviate pain-related
aversion sentiment in rats with BCP.
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Background
Bone pain associated with cancer metastasis is the most
severe pain among cancer patients and is often resistant
to current analgesics. However the biological mechanisms
for its onset are not fully understood [1]. Advanced cancer
patients with BCP suffer from malignant emotional
experience such as anxiety, fear, loneliness and even
worldweariness. Physical and psychological harm to pa-
tients are more severe than the pain itself [2, 3]. Therefore,
alleviation of malignant emotional experience represents
an important component of clinical care for improving
the quality of life among advanced cancer patients. How-
ever, few studies have investigated pain-related aversion
sentiment.
Johansen has shown that aversion response could
be weakened by formalin injection in plantar after
AP-5 (non-selective NMDA receptor antagonist) ad-
ministration into ACC [4]. In this study, we aimed to
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investigate the therapeutic effect of ifenprodil as a se-
lective NR2B receptor antagonist administrated into
rACC on BCP-related aversion sentiment.
Methods
Animals and grouping
The experiments were performed using 30 male Wistar
rats, weighing 230–250 g and 5–7 weeks old (from
Experimental Animal Research Center of Shandong
University). The rats accessed to food and water freely in
a controlled temperature (22–24 °C) and humidity (40–
60%). My manuscript reporting adhered to the ARRIVE
guidelines for the reporting of animal experiments.
Rats were randomly assigned to three groups.
Group C (n = 10) served as control group. Group P
(n = 10) received injection of 3 μl MADB-106 cells
(4.8 × 109/ml) and served as BCP group. Group Ifen
(n = 10) received injection of cells and followed by
ifenprodil administration into rACC.
Establishment of rat BCP model
The MADB-106 cells were maintained in Dulbecco’s
Modified Eagle’s Medium, supplemented with 10% Fetal
bovine serum, 100 unit/ml penicillin, and 100 μg/ml
streptomycin; and cultured at 37°C in a humidified at-
mosphere of 5% CO2; and then passaged weekly accord-
ing to ATCC guidelines. For administration, cells were
detached by scraping and then centrifuged at 900 rpm
for 3min. The pellet was suspended in Hank’s balanced
salt solution and then used for intra-tibial injection. Rat
BCP model was prepared according to protocols of previ-
ous studies [5, 6]. Three microliter MADB-106 cells were
injected into the bone marrow of right tibia except control
group under pentobarbital (50 mg/kg) anesthesia. The
implantation technique of the intrathecal catheter was
modified and performed [7, 8]. The skin was closed with
3–0 silk sutures. After surgery, rats were housed in indi-
vidual cages. To avoid occlusion of the catheter, 10 μl of
normal saline was injected via a catheter on alternate days
until the end of the experiment.
Ifenprodil administration into rACC
rCAA was located using stereotaxic instrument. A
polyethylene-10 catheter was inserted under pentobar-
bital anesthesia. The catheter was passed 2.5 cm caudally
through an incision and the external part of the catheter
was tunneled subcutaneously. 0.2 g/L ifenprodil of nor-
mal saline was injected via a catheter in group Ifen
(0.6 μl each side), and the same dose of normal saline
was used in groups C and P.
Pain thresholds analysis
Von Frey instrument was used for analysis of pain thresh-
olds induced by mechanical stimulation at different time
points. The rats were acclimated to the environment for
20min, and the plantar of their paws were stimulated.
Value of the reaction to stimulation within 20s was
regarded as pain thresholds. The measurement was re-
peated for three times with 5min interval, and the average
value was taken. The procedure was the same as in
contralateral side. The rats were kept in the same status
during the process.
CPA analysis
CPA analysis began at 12 days after injection of cells
when pain to stimulation was obvious. Training box
consisted of opaque rooms A (condition training
room) and B (control room) placed side by side.
There were significant differences in visual, tactile
and olfactory information. Room A was characterized
by black and white vertical stripes on the wall, rough
floor and interior drops of 1% acetic acid as the odor-
ant, and room B by black and white horizontal stripes
on the wall, smooth floor and 1% cinnamon water.
Recording system could automatically record
residence time of rats in each room. On first day
(pre-training), the rats with BCP explored the box for
20min and could freely enter the room A or B, and
time in each room was record. On second day
(training period), operated hind paws were stimulated
with Von Frey filaments (60 g) every 30s to induce
emotional responses when the rats entered room A,
while stimulation was given to lateral hind paws when
the rats entered room B. On the last day (test
period), the time in each room was recorded within
20min, no stimulation was given. Time percentage in
room A was calculated.
Ifenprodil injection site in rACC
Microinjection sites of ifenprodil marked with 0.6 μl
saturated Chicago sky blue 6 B were injected into
rACC after CPA experiment. Anterior cingulated cor-
tex tissue was obtained and dehydrated using graded
sucrose at 4 °C after perfusion with 4% formaldehyde
(pH = 7.2). Microinjection sites and diffusion range
were analyzed with Paxinos and Watson stereotaxic
atlas after consecutive coronal slices (35 μm) [8]. Sites
deviated from rACC were not included in the results.
Statistical analysis
Statistical analysis was done using SPSS 17.0 statistical
software. Measurement data was expressed as mean ±
standard deviation, different time points in group were
compared using repeated measures analysis of variance,
one-way analysis of variance was used between groups.
P < 0.05 was considered statistically significant.
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Results
Pain thresholds changes of operated jaw in rats
Pain thresholds of rats’ operated jaw decreased significantly
in groups P and Ifen compared to group C at 10 days after
injection of MADB 106 cells and remained low at 12 and
14 days (P < 0.05). There was no changes in group C. Be-
tween groups, pain thresholds was lower in groups P and
Ifen at 10, 12 and 14 days than that in group C (P < 0.05)
(Table 1).
Room residence time in different groups
Residence time in room A was (30 ± 4%) in group P,
shorter than (52 ± 5%) in group C (P < 0.05). In group
Ifen, residence time in room A was decreased to (42 ±
5%), which longer than that in group P and still shorter
than that in group C (P < 0.05) (Table 2).
Histological examination of Ifenprodil injection site
The results showed that one in group C, one in group
Ifen and two in group P were excluded because of incor-
rect administration. Ifenprodil injection sites and the dif-
fusion range are shown in Fig. 1.
Discussion
Bone metastasis-induced pain manifests as spontaneous
pain, hyperalgesia, and allodynia [9]. Pain that is severe
enough to compromise daily life affects about 36–50% of
cancer patients [10]. Therefore, studies about BCP are
important in clinical practice. MADB-106 breast cancer
cell line of rat was from breast cancer lung metastasis
(MADB-100) and cultured with Fish 344 rat. Applica-
tions of MADB-106 cells in rat model with BCP have
achieved high success rate. In our study, the rats had sig-
nificant hyperalgesia at 10 days after injection of
MADB-106.
Rats exhibit avoidance behavior when exposed to pain-
ful stimuli, and this pain-related information is stored in
the memory. Rats can avoid noxious stimuli through
forecast because of the bad memories of painful emo-
tional experience when the pain stimuli appear again.
Thus, avoidance behavior of rats to painful stimuli may
reflect pain aversion. Our results showed avoidance of
rats with BCP from room A the next day after received
mechanical stimulation, and this avoidance behavior in
rats resulted from bad memories of pain experience.
Thus, residence time in room A could reflect pain re-
lated aversion in rats with BCP.
ACC neurons are involved in emotional processing of
pain, making it an attractive target for therapeutic inter-
vention on pain-related aversion [11, 12]. Ifenprodil
injection was used in this study to investigate the
therapeutic effect on pain-related aversion, and we
used saturated Chicago sky blue 6B to confirm injec-
tion sites in rACC. Residence time in room A became
longer after the rats with BCP received ifenprodil in-
jection into rACC, suggesting that pain related aver-
sion alleviated. Clinical observations suggested that
anxiety, depression and other negative emotions of
patients with intractable pain could be significantly al-
leviated after ACC and the surrounding cortex were
removed. Rainville found that pain-related aversion
became worse when the stimulus intensity increased,
or ACC neurons excitement level increased [13].
Microinjection of non-selective NMDA receptor an-
tagonist AP-5 into ACC could block formalin-induced
conditioned place avoidance [4]. This indicated that
NMDA receptors in ACC neurone play an important
role in the generation and maintenance of chronic
pain to vicious emotional experience. NMDA receptor
consists of NR1 subunit and NR2A/NR2B subunit in
amygdala and prefrontal cortex. Chronic inflammatory
pain response increased with expression of NR2B in
forebrain [14], and expression of NR2B in ACC up-
regulated after plantar subcutaneous injection of CFA
to produce inflammatory pain [15]. Taken together
with our study results, these data suggest that NR2B
receptor in rACC neurons plays an important role in
pain-related aversion and can be a potential thera-
peutic target for treatment of BCP associated with
disgust.
Table 1 Pain thresholds of operated jaw in rats
Group Preoperation Postoperation (d)
3 7 10 12 14
Group C (n = 9) 12.0 ± 2.4 11.6 ± 2.8 12.2 ± 2.6 12.4 ± 2.2 12.0 ± 2.1 11.8 ± 2.1
Group P (n = 8) 12.2 ± 2.1 10.5 ± 2.2 10.2 ± 2.6 7.3 ± 2.1ab 5.8 ± 1.8ab 5.2 ± 1.4ab
Group Ifen (n = 9) 11.9 ± 1.8 11.2 ± 2.2 10.8 ± 2.4 7.8 ± 2.3ab 5.4 ± 1.2ab 5.0 ± 1.8ab
aP < 0.05,vs group C, bP < 0.05 vs postoperation
Table 2 Time percentage in room A in all rats
Group Time percentage (%)
Group C (n = 9) 52 ± 5
Group P (n = 8) 30 ± 4a
Group Ifen (n = 9) 42 ± 5ab
aP < 0.05 vs group C, bP < 0.05 vs group P
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Conclusions
Injection of selective NR2B receptor antagonist ifenpro-
dil into rACC regions could significantly reduce aversion
associated with BCP in rats. Our study provides a new
approach for clinical treatment and research of BCP-
related aversion.
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Fig. 1 Histological examination of injection sites of ifenprodil in
rACC (arrows show the sites and diffusion range)
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